# Cipla Limited – FDA Inspection, Feb 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/cipla-limited/69b7c844-7159-454b-b581-1a728cf834a1
Source feed: FDA_Inspections

> FDA inspection 1198343 of Cipla Limited, February 17, 2023. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR parts 211 and 314. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198343
- Company Name: Cipla Limited
- Inspection Date: 2023-02-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1331746 - 2026-08-25](https://www.keypedia.com/records/fda_inspections/cipla-limited/8e984a05-d69e-4ebb-beb1-b0eca787a4ba)
- FDA Inspection 1094880 - 2019-05-17
- [FDA Inspection 1048005 - 2018-04-13](https://www.keypedia.com/records/fda_inspections/cipla-limited/e8143ba3-08be-4081-940c-dd76d60ee6da)
- [FDA Inspection 1019068 - 2017-06-23](https://www.keypedia.com/records/fda_inspections/cipla-limited/8d1e8e30-55f5-46d8-9263-32aedd2aef4f)
- FDA Inspection 1007876 - 2017-01-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)

Company: https://www.keypedia.com/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c